Should Colchicine Become Standard Therapy for CAD?

Canadian Collaborative Research Network

P. Ridker

Cardiology’s Biggest Controversy: The Lumen or the Wall - the Curiou…

Cedars Sinai

J. Forrester

TCT 2024 Insights: A Contemporary Analysis and Outcomes of Orbital A…

TCT 2024 Insights

H. Amin

TCT 2024 Insights: Insights from the DanGer Shock and ECLS-Shock Tri…

TCT 2024 Insights

G. Tarantini

Basics of OCT Imaging

FACET

N. Pinilla-Echeverri

Q&A: Are We Underusing CABG?

Cedars Sinai

J. Chikwe

Hemodynamic vs. Hemo-Metabolic Shock: Redefining Shock Profiles

The Cardiogenic Shock Working Group

N. Kapur

The History of Invasive Cardiac Procedures - Updated

Joel Gorfinkel

High-Risk Cardiac Surgery and Pre-Op Optimization with Impella Base …

St. Louis Shock & Heart Failure Symposium 2022

J. Leidenfrost

Contemporary Management of Cardiogenic Shock: Updates in 2022

Mount Sinai Advanced Innovations in Heart Failure

D. Baran

The Past, Present and Future of the Total Artificial Heart

The Texas Heart Institute

W. Cohn, O. Frazier

ESC 2024 Insights: Comparison of Different Calcium Modification Stra…

ESC 2024 Insights

K. Yasumura

Use of MCS in Management of Acute Post-MI VSD

Houston Shock Symposium

D. Ramini

Is FFR Dead? Addressing Contrarian FFR Studies

Scottsdale Interventional Forum 2023

M. Kern

Cardiogenic Shock: Should IABP or PVADs Be Used in Cardiogenic Shock?

American Heart & Vascular Institute

M. Ansari

Intermediate Lesions: Beyond the Oculo-Stenotic Reflex

Northwell Health Cardiovascular Fellows Course 2022

R. Jauhar

Ultra-Low Contrast PCI

ARCH Advanced Revascularization Symposium

J. Kerrigan